DERM Health Economics Study
- Status
- COMPLETED
- Phase
- N/A
Clinical Trials Related to Melanoma
Related studies linked through entity extraction aliases.
Focused Ultrasound Ablation and PD-1 Antibody Blockade in Advanced Solid Tumors
- Status
- TERMINATED
- Phase
- PHASE1
Anti-PD-1 mAb Plus Metabolic Modulator in Solid Tumor Malignancies
- Status
- RECRUITING
- Phase
- PHASE2
Microbiome Immunotherapy Toxicity and Response Evaluation
- Status
- UNKNOWN
- Phase
- N/A
Long-term, Non-interventional, Observational Study Following Treatment With Fate Therapeutics FT500 Cellular Immunotherapy
- Status
- TERMINATED
- Phase
- N/A
Effectiveness Study of Nivolumab Compared to Placebo in Prevention of Recurrent Melanoma After Complete Resection of Stage IIB/C Melanoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
Safety and Efficacy of SB 11285 Alone and in Combination With Atezolizumab in Patients With Advanced Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
Nivolumab/Ipilimumab Plus Cabozantinib in Patients With Unresectable Advanced Melanoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Atezolizumab in Combination With Bevacizumab in Patients With Unresectable Locally Advanced or Metastatic Mucosal Melanoma
- Status
- COMPLETED
- Phase
- PHASE2
GEN1042 Safety Trial and Anti-tumor Activity in Participants With Malignant Solid Tumors
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
Study of ARRY-614 Plus Either Nivolumab or Nivolumab+Ipilimumab
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
Study of NGM120 in Subjects With Advanced Solid Tumors, Pancreatic Cancer, and Prostate Cancer Using Combination Therapy
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Talimogene Laherparepvec With Pembrolizumab in Melanoma Following Progression on Prior Anti-PD-1 Based Therapy (MASTERKEY-115) (Mk-3475-A07/KEYNOTE-A07).
- Status
- COMPLETED
- Phase
- PHASE2
ADP-A2M4CD8 as Monotherapy or in Combination With Either Nivolumab or Pembrolizumab in HLA-A2+ Subjects With MAGE-A4 Positive Tumors (SURPASS)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Interest of Tumor Replicates in Avian Embryo to Model Therapeutic Effects of BRAFi/MEKi in BRAF Mutated Melanoma
- Status
- COMPLETED
- Phase
- NA
Fecal Microbiota Transplantation in Treating Immune-Checkpoint Inhibitor Induced-Diarrhea or Colitis in Genitourinary Cancer Patients
- Status
- RECRUITING
- Phase
- PHASE1
Symptom Management for YA Cancer Survivors
- Status
- COMPLETED
- Phase
- NA
A Study of Ladiratuzumab Vedotin in Advanced Solid Tumors
- Status
- TERMINATED
- Phase
- PHASE2
The Registry of Oncology Outcomes Associated with Testing and Treatment
- Status
- COMPLETED
- Phase
- N/A
Genetic Predictors of Efficiency and Safety of ICIs in Patients With Different Malignancies (ICIPRESIST-0519)
- Status
- UNKNOWN
- Phase
- N/A